Unveiling of a new production unit in France
All the news from Servier Group
Open innovation: 3 Compelling Reasons to choose a Public-Private Partnership in Healthcare
Life after cancer: learning to live differently, a challenge for survivors
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Servier is awarded the Gallup Exceptional Workplace Award for the second consecutive year
Servier’s 2023-2024 Annual Integrated Report is now available!
Women in science: fostering innovation in tech and science companies!
Blue March 2025: More determined than ever to combat colorectal cancer
International rare disease day 2025: our teams at the forefront